A new clinical trial is investigating the efficacy of CBD-infused mouthwashes and toothpaste when used to treat gum disease.

The randomised controlled clinical trial is a collaboration between Australian medicinal cannabis business Impression Healthcare and US-based pharmaceutical-grade medical cannabis producer AXIM Biotechnologies.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us